Lupus nephritis is inflammation of the kidneys caused by systemic lupus erythematosus (SLE), an autoimmune condition where your body's immune system mistakenly attacks its own tissues. Between 40 to 60 percent of people with SLE develop kidney involvement, making early detection and proper management critical to preserving kidney function. Understanding how lupus affects your kidneys and what treatment options are available empowers you to work with your healthcare team to slow progression and maintain the best possible quality of life.
What Is Lupus Nephritis and Why Does It Matter?
Lupus nephritis occurs when the immune system forms antibodies that attack the glomeruli, tiny blood vessels inside your kidneys that filter waste. This inflammation damages the kidney tissue and disrupts normal filtration, allowing protein and blood cells to leak into your urine.
Lupus nephritis is one of the most serious complications of SLE because untreated kidney disease can lead to chronic kidney disease or kidney failure, requiring dialysis or transplantation.
Early diagnosis and aggressive treatment can slow or halt this progression. Your kidneys are vital organs that work silently; often, kidney involvement has no obvious symptoms until significant damage has occurred, which is why regular monitoring is essential if you have SLE.
What Causes the Kidneys to Be Attacked in Lupus?
In SLE, the immune system produces autoantibodies, most notably anti-dsDNA antibodies, that form immune complexes. These complexes circulate in the blood and lodge in the glomeruli, the tiny filtering structures in each kidney.
The body's own inflammatory response to these deposits is what damages kidney tissue, not an external infection or toxin.
Certain factors raise the risk of the kidneys being involved:
-
Sex and age: LN tends to be more aggressive in men and in younger patients with lupus, even though SLE itself is far more common in women.
-
Ethnicity: Asian, African, and Hispanic patients with lupus have consistently shown a higher likelihood of developing lupus nephritis and a faster progression to kidney failure compared with white patients.
-
Antibody profile: Patients who are anti-dsDNA positive are more likely to develop kidney involvement than those who are not.
Early Warning Signs and Symptoms of Lupus Nephritis
Lupus nephritis can develop gradually, and symptoms may vary depending on how much the kidneys are affected.
The silent early stage
In its earliest stages, lupus nephritis frequently has no noticeable symptoms. This is precisely why routine urine and blood testing is recommended for every lupus patient, not just those who feel unwell.
Signs that usually prompt a visit
- Foamy or bubbly urine (a sign of excess protein, proteinuria)
- Blood in the urine (may or may not be visible to the eye)
- Swelling in the ankles, feet, hands, or around the eyes
- New or worsening high blood pressure
- Unexplained weight gain from fluid retention
- Increased night-time urination
If any of these appear alongside a lupus diagnosis or a family history of autoimmune disease, a nephrology evaluation should not be delayed.
How Is Lupus Nephritis Diagnosed?
Doctors use a combination of urine, blood, and sometimes kidney biopsy findings to confirm lupus nephritis and determine how severely the kidneys are affected.
Step 1: Urine and blood tests
A urine protein-to-creatinine ratio, urine microscopy (checking for red cells and casts), serum creatinine, complement levels (C3/C4), and anti-dsDNA antibody titers together give the first picture of kidney involvement.
Step 2: The kidney biopsy
A biopsy is the only way to confirm the exact class of lupus nephritis, which in turn decides the treatment plan. Pathologists use the ISN/RPS classification system, most recently detailed by KDIGO's 2024 guideline update
| Class | What It Means | Typical Approach |
|---|---|---|
| I | Minimal mesangial changes, often silent | Monitoring only |
| II | Mesangial proliferative changes | Monitoring; treat if other organs are affected |
| III | Focal (less than 50% of glomeruli involved) | Immunosuppressive therapy |
| IV | Diffuse (50% or more of glomeruli involved) | Aggressive immunosuppressive therapy |
| V | Membranous lupus nephritis | Immunosuppression + blood pressure control |
| VI | Advanced sclerosing disease (over 90% scarring) | Renal replacement (dialysis/transplant) considered |
Lupus Nephritis Treatment: A Class-by-Class Approach
Treatment depends on how much kidney damage the biopsy shows, with milder classes often needing monitoring rather than aggressive kidney-specific therapy.
Class I & II: Watchful monitoring
These early classes rarely need kidney-specific drugs. Instead, nephrologists track urine protein and kidney function every few months and treat lupus activity in other organs as needed.
Class III & IV: Induction, then maintenance
This is where most lupus nephritis treatment decisions happen.
-
Induction phase (first 3–6 months): High-dose corticosteroids combined with either mycophenolate mofetil or intravenous cyclophosphamide, often alongside a third agent (a calcineurin inhibitor or belimumab).
-
Maintenance phase (ongoing, often 3–5 years): Lower-dose immunosuppression, usually mycophenolate or azathioprine, to sustain remission and taper steroids as fast as safely possible.
Class V: Membranous lupus nephritis
Managed with immunosuppression similar to Class III/IV when nephrotic-range protein loss is present, plus strict blood pressure control using ACE inhibitors or ARBs, which also reduce proteinuria directly.
Class VI: Advanced disease
By this stage, active immunosuppression is unlikely to reverse damage. Care shifts toward supportive management of chronic kidney disease and, when kidney function has declined significantly, dialysis or transplant planning.
Living With Lupus Nephritis: Monitoring, Diet, and Follow-Up
-
Test regularly, even in remission: urine protein-to-creatinine ratio, serum creatinine, and complement levels every 3–6 months, or sooner if a flare is suspected.
-
Watch salt, sodium, and protein intake as advised by your nephrologist, particularly during active proteinuria.
-
Control blood pressure aggressively, it is both a cause and consequence of kidney damage in LN.
-
Never stop immunosuppressants abruptly without medical guidance, even when urine tests normalise; premature withdrawal is a well-documented trigger for flares.
-
Track medication side effects (infection risk, bone health, fertility considerations) with your care team rather than adjusting doses independently.
Why Patients From Kerala and Abroad Choose Meitra Hospital for Kidney Care
For lupus nephritis, the quality of nephrology care matters, but so does having the right specialists, diagnostics and renal support available when needed. Meitra Hospital, Kozhikode, offers these services within an integrated hospital setting.
Patients may benefit from:
-
Multidisciplinary specialist support: Nephrology can coordinate with other specialties when lupus affects organs beyond the kidneys.
-
NABH and NABL accreditation: Standardised clinical processes and accredited laboratory services support consistent diagnosis and monitoring.
-
Advanced renal care: Access to dialysis, SLED, plasmapheresis/plasma exchange and kidney transplantation when clinically required.
-
Support for patients travelling from outside Kerala: Assistance with appointments, investigations, treatment coordination and other practical aspects of care.
-
International patient support: Services designed to help patients travelling from the Gulf and other countries manage their treatment at one centre.
For lupus nephritis, these facilities work best alongside the essentials: accurate biopsy assessment, experienced nephrology care, appropriate treatment and regular monitoring.
Conclusion
Lupus nephritis treatment depends on the biopsy class, kidney function and level of active inflammation. Medicines such as corticosteroids, immunosuppressants, belimumab and voclosporin may be used depending on the individual case.
Regular urine protein, kidney function and blood pressure checks, along with timely nephrology follow-up, can help detect worsening disease early. The goal is to control inflammation, reduce protein loss and protect kidney function over the long term.
Kidney involvement in lupus can progress quietly, so answers matter more than assumptions. You can chat with our medical assistant for quick guidance on symptoms or appointment booking.
Medical Disclaimer: This article is intended for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Lupus nephritis is a complex condition, and treatment decisions must be individualised by a qualified nephrologist or rheumatologist based on a patient's clinical history, laboratory results, and biopsy findings. Please consult a healthcare professional for any concerns about your health or before making any treatment decisions.
